DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Receives $28.40 Average Price Target from Brokerages

Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) have been given a consensus rating of “Hold” by the twelve analysts that are covering the firm, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $27.91.

A number of brokerages recently weighed in on XRAY. Evercore ISI dropped their price target on DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, October 8th. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. UBS Group lowered their price objective on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Robert W. Baird reduced their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a report on Friday, November 8th. Finally, Leerink Partners lowered DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th.

DENTSPLY SIRONA Stock Down 2.7 %

XRAY stock opened at $18.68 on Monday. The firm has a market cap of $3.71 billion, a PE ratio of -9.02, a P/E/G ratio of 1.93 and a beta of 0.96. DENTSPLY SIRONA has a 12 month low of $17.21 and a 12 month high of $37.60. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a 50 day simple moving average of $21.07 and a 200 day simple moving average of $24.04.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million during the quarter, compared to the consensus estimate of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Shareholders of record on Friday, December 27th will be paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 3.43%. The ex-dividend date of this dividend is Friday, December 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently bought and sold shares of the business. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 33.6% during the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after purchasing an additional 3,283,965 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock valued at $110,118,000 after buying an additional 1,308,411 shares during the last quarter. Cooke & Bieler LP raised its holdings in DENTSPLY SIRONA by 16.2% in the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock worth $186,996,000 after acquiring an additional 1,046,105 shares during the period. Invenomic Capital Management LP bought a new position in DENTSPLY SIRONA in the 3rd quarter worth $23,724,000. Finally, National Bank of Canada FI grew its position in shares of DENTSPLY SIRONA by 684.6% in the second quarter. National Bank of Canada FI now owns 876,400 shares of the medical instruments supplier’s stock valued at $21,586,000 after purchasing an additional 764,700 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.